lenalidomide has been researched along with thromboplastin in 2 studies
| Studies (lenalidomide) | Trials (lenalidomide) | Recent Studies (post-2010) (lenalidomide) | Studies (thromboplastin) | Trials (thromboplastin) | Recent Studies (post-2010) (thromboplastin) |
|---|---|---|---|---|---|
| 3,532 | 725 | 2,850 | 10,540 | 281 | 2,126 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asmis, LM; Kaech, A; Leikauf, MS; Madon, J; Ruf, W; Valsami, S | 1 |
| Arai, R; Fujimoto, K; Isozumi, Y; Koyama, T | 1 |
2 other study(ies) available for lenalidomide and thromboplastin
| Article | Year |
|---|---|
Immunomodulatory drugs increase endothelial tissue factor expression in vitro.
Topics: Cell Line; Endothelial Cells; Humans; Immunologic Factors; Lenalidomide; RNA, Messenger; Thalidomide; Thromboplastin; Umbilical Veins; Up-Regulation | 2011 |
Activation of coagulation by lenalidomide-based regimens for the treatment of multiple myeloma.
Topics: Blood Coagulation; Boronic Acids; Bortezomib; Cell Line; Cell Line, Tumor; Dexamethasone; Humans; Lenalidomide; Multiple Myeloma; Phosphatidylserines; Pyrazines; Thalidomide; Thromboplastin | 2013 |